FrontPoint To Close Healthcare Funds Under Insider-Trading Cloud

Nov 19 2010 | 7:43am ET

FrontPoint Partners will liquidate its healthcare hedge funds in the wake of an insider-trading scandal.

The Greenwich, Conn.-based hedge fund plans to close the funds and return the $1.5 billion they manage to investors by the end of the month, Bloomberg News reports. The move follows the suspension of lead healthcare manager Joseph Skowron earlier this month, following the arrest of a French doctor accused of passing confidential information on to several hedge funds.

Neither Skowron nor FrontPoint, which is being spun-off from Morgan Stanley, have been accused of any wrongdoing. But FrontPoint acknowledges that it is one of the unidentified hedge funds referred to in Yves Benhamou’s insider-trading indictment. The indictment says Benhamou passed a tip about a disappointing drug trial at Humane Genome Sciences to a “co-portfolio manager” at the fund—that person is believed to be Skowron. Trading on the tip allegedly allowed FrontPoint to avoid $30 million in losses after news of the drug trial became public.

FrontPoint said it is cooperating fully with the investigation. Benhamou has denied any wrongdoing.

Investors have already been heading for the door: Clients filed redemption requests totaling about half of the funds’ assets within a week of Benhamou’s arrest.


In Depth

Q&A: Star Mountain's Brett Hickey On Investing In 'The Growth Engine Of America'

Sep 22 2017 | 5:06pm ET

Lower middle-market companies form the economic fabric of the nation, but they can...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

Don’t Overlook These 6 Hybrid Cloud Concerns

Sep 14 2017 | 6:27pm ET

Cloud-based technology solutions have made tremendous inroads into the alternative...

 

From the current issue of

Business Insider has been reporting on the unusual trading activity of a mystery trader who placed a profitable short equity bet to the tune of $21 million on the Aug. 10 move in the CBOE Volatility Index (VIX).